Akebia Therapeutics Inc (NASDAQ:AKBA)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - AKBA
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - AKBA
- Market Cap$440.840m
- SymbolNASDAQ:AKBA
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS00972D1054
Company Profile
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.
Latest AKBA news
Currently there for this company. Visit our news hub for other news .